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ABSTRACT
OBJECTIVE: To verify the spatial pattern of mortality from breast and cervical cancer in areas 
of primary health care, considering socioeconomic conditions.
METHODS: This is an ecological study, from January 2000 to December 2016. The study 
area is the municipality of São Paulo, Brazil, and its 456 coverage areas of primary health 
units. Information on deaths of women aged 20 years or over were geocoded according to 
residence address. We calculated mortality rates, standardized by age, and smoothed by the 
local empirical Bayesian method, and grouped into three or two years to reduce the random 
fluctuation of the data. In addition, bivariate global and local Moran indexes were calculated 
to verify the existence of spatial agglomeration of standardized mortality rates with a domain 
of socioeconomic condition, elaborated based on the Índice Paulista de Vulnerabilidade Social 
(IPVS – São Paulo Index of Social Vulnerability).
RESULTS: The success rate of geocoding was 98.9%. Mortality from breast cancer, without 
stratification by time, showed a pattern with higher rates located in central regions with better 
socioeconomic conditions. It showed a decrease at the end of the period and a change in spatial 
pattern, with increased mortality in peripheral regions. On the other hand, mortality from 
cervical cancer remained with the highest rates in peripheral regions with worse socioeconomic 
conditions, despite being reduced over time.
CONCLUSION: The spatial pattern of mortality from the studied cancers, over time, suggests 
association with the best socioeconomic conditions of the municipality, either as protection 
(cervical) or risk (breast). This knowledge may direct resources to prevent and promote health 
in the territories.
DESCRIPTORS: Breast Neoplasms. Uterine Cervical Neoplasms. Spatial Analysis. Socioeconomic 
Analysis. Mortality.
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INTRODUCTION
Breast and cervical cancer are important global public health problems. In Brazil, breast 
cancer in the female population increased between the estimates of 2018–2019 and 2020–
2022, and remained as the most incident cancer, except for non-melanoma skin cancer. 
Cervical cancer is one position up and is now the third most incident. Both cancers are also 
important causes of mortality in the country1–3.
In the municipality of São Paulo (MSP), between 2008 and 2012, the mean annual mortality 
rate from breast cancer, standardized by age, was 16.2 per 100 thousand women-year, and, 
for cervical cancer, 3.7 deaths per 100 thousand women-year, with a tendency to decrease 
in the first cancer and stability in the second4.
Some studies performed in the MSP, from 1985–1999 and 2010–2012, verified that regions 
with better socioeconomic conditions had a higher risk of mortality from breast cancer. 
Regions with worse socioeconomic conditions, on the contrary, indicated a higher risk of 
mortality from cervical cancer when compared to the other analyzed territories5,6.
This study aimed to verify the spatial pattern of mortality from breast and cervical cancer 
in women aged 20 years or over, living in the MSP, from 2000 to 2016, comparing these 
cancers and considering the socioeconomic conditions of the municipality, in areas covered 
by primary health care.
METHODS
The study design was ecological, using secondary data, from January 2000 to December 
2016. The study area corresponded to the municipality of São Paulo, located in the state of 
São Paulo (SSP), Brazil (Figure 1A), with population of 11,811,516 inhabitants and population 
density of 7,765.06 inhabitants/km² in 20197. The units of analysis were the 456 coverage 
areas of the primary health units in the MSP (CA), version 2015/2016. These areas allow 
the local health administrator to know the specific conditions of each territory, including 
sociodemographic, environmental, epidemiological and production characteristics8.
The digital mesh of the CA was provided by the Municipal Health Department of São Paulo 
(SMS-SP). Figure 1B indicates the distribution of the socioeconomic domain (DS-IPVS) 
for 2010 (demographic census), according to the CA (version 2015/2016). This domain 
corresponds to the variable factor 1 (v36), referring to the socioeconomic factor of the Índice 
Paulista de Vulnerabilidade Social (IPVS – São Paulo Index of Social Vulnerability), calculated 
to each census sector (CS). The higher this value, the better the socioeconomic level. The 
IPVS is an instrument that can be used to evaluate public policies, since it provides greater 
detail, according to the spatial location, of the living conditions of the municipality, such 
as vulnerability to poverty9.
To estimate the DS-IPVS by CA, a geographic operation was performed, in order to verify 
the proportion of each CS inserted in each CA. This proportion was applied to the resident 
population and multiplied by the variable v36. Then, each product belonging to the 
geographic delimitation of the CA was added, and this value was divided by the sum of 
the population of that area, thus obtaining a weighted mean. It is noteworthy that 1,537 of 
the total of 18,923 CS were classified as ignored, since they are areas without population 
or with reduced population. These CS were disregarded when elaborating the indicator.
Figure 1B also shows the Coordenadorias Regionais de Saúde (CRS – Regional Health Coordinators), 
being: I – North; II – West; III – Downtown; IV – Southeast; V – East; and VI – South.
Information regarding deaths from breast cancer (BC) (CID-10 from C50 to C50.9) and 
cervical cancer (CC) (CID-10 from C53 to C53.9) of women living in the MSP aged 20 years 
or over were obtained by formal request to SMS-SP10.
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The addresses of the deaths were geocoded, using mainly the Padronizador de Endereços da 
Prefeitura Municipal de São Paulo (PAD-PMSP – Address Standardizer of the São Paulo City 
Hall), by Prodam. This application uses official and unofficial databases, with the ability 
to process large volumes of records. The addresses not geocoded in the standardizer were 
geocoded by geolocation platforms that used Google Maps as base for streets and by an 
application that uses the Navteq street base.
Demographic information was obtained from the Brazilian Institute of Geography and 
Statistics (IBGE) for the census years from 2000 to 2010, initially aggregated by CS and 
posteriorly attributed to the CA through a geographical operation between the layers, 
attributing values proportional to the areas.
Then, we calculated the mortality rates standardized by age, using the direct method and 
the standard population of the World Health Organization (WHO)11, considered the most 
adequate for developing countries. All referred mortality rates have magnitude “per 100 
thousand women aged 20 years or older-year” but were described as “100 thousand women-
year. These rates were calculated for the whole period (2000–2016) and also for six periods 
(2000–2002, 2003–2005, 2006–2008, 2009–2011, 2012–2014 and 2015–2016). These groupings 
were used to reduce the random fluctuation of data and to perform the visual comparison 
of the rates according to the units of analysis, arranged in thematic maps.
The maps were also represented by a rate smoothing method – local empirical 
Bayesian – elaborated from the distance neighborhood matrix, with the five neighbors’ 
Figure 1. A) Municipality of São Paulo, State of São Paulo, SP, Brazil, South America. B) Distribution of 
the socioeconomic domain of the São Paulo Social Vulnerability Index (DS-IPVS) according to Areas 
of Coverage of Basic Health Units. Municipality of São Paulo, 2010.
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criterion (value corresponding to the average of neighbors), using the expected deaths, 
standardized by age, as the event of  interest in the numerator. The estimate for obtaining 
the expected deaths was calculated by multiplying the sum of the observed population, 
in a given CA and study period, by the value of the corresponding standardized rate, 
divided by 100 thousand. In the denominator, we used the population corresponding 
to the middle of the period (population of 2010, provided by the census and estimated 
for each CA). Finally, to obtain annual rates, the smoothed rates were divided by the 
number of study years.
Age standardization, for the local Bayesian smoothing method, is not usually described 
in literature; however, considering that age is an important confounding factor in the 
study of neoplasms, due to age differences between populations, such standardization 
was necessary.
In addition, we calculated the bivariate local and global Moran indexes, in order to verify 
the existence of spatial agglomeration in the bivariate analysis between standardized 
mortality rates and socioeconomic domain. The significance value was calculated by 
the Monte Carlo hypothesis test, with 999 random replications (considered significant 
if less than 0.05)12.
The applications used to geocode the addresses were: Padronizador de Endereços da 
Prefeitura Municipal de São Paulo (PAD-PMSP), API Google, BatchGeo and Maptitude. 
Neighborhood matrix, local empirical Bayesian rates and bivariate local and global Moran 
indexes were calculated in the GeoDa application, version 1.12.1.161. The construction and 
manipulation of databases, the population estimates for non-census years, the estimates 
of standardized mortality rates by age and all the elaboration of thematic maps and graphs 
were performed in the R Studio software, version 1.3.1093. Thematic maps used the “quantile” 
category, except for the map with the Moran indexes, which was shown as a “categorical” 
criterion. Geocoding operations were performed in the QGIS software, version 2.18. 
This study was linked to a larger project, approved by the Research Ethics Committee of 
the Faculdade de Saúde Pública of  Universidade de São Paulo (CAAE: 76049317.7.0000.5421; 
opinion number: 2.412.427) and of the City Hall of São Paulo (CAAE: 76049317.7.3001.0086; 
opinion number: 2.467.549).
RESULTS
In all, 24,120 address records were geocoded out of a total of 24,386 (success rate of  98.9%). 
Of these, 19,652 were related to BC (99.0% of 19,856 records) and 4,468 to CC (98.6% of 
4,530 records).
Figures 2A-I and 2B-I show the average local empirical Bayesian mortality rates according 
to CA, over the entire period. For BC, there is a concentration of higher rates in the West 
(central part), Downtown and Southeast (upper part) CRS and in a portion of the North 
CRS. As for CC, the highest rates are concentrated in the South, East and North CRS.
In 2010, the regions of the MSP with the best socioeconomic conditions were the West and 
Downtown CRS (Figure 1B). A decline in socioeconomic level is perceived the more peripheral 
the areas are (or towards the periphery). The comparison of these conditions with mean 
local empirical Bayesian mortality rates, over the entire period, is shown in Figures 2A-II 
and 2B-II, for BC and CC, respectively.
When comparing Figures 2A-II and 2B-II we observed: (i) a spatially positive and significant 
relation between mortality from BC and the socioeconomic conditions given by the 
DS-IPVS, and (ii) a negative and significant relation between mortality from CC and 
DS-IPVS. Therefore, it is noted that areas with high mortality rates from BC, in general, 
have neighboring areas with high DS-IPVS (better socioeconomic conditions). 
5
Breast and cervical cancer: mortality Bermudi PMM et al.
https://doi.org/10.11606/s1518-8787.2020054002447
For BC, the areas with a “high-high” pattern (high mortality rates and high DP-IPVS values in 
the neighbors) were concentrated in the West, Downtown and Southeast CRS. The “low-low” 
areas (low mortality rate and low DS-IPVS values in the neighbors) were concentrated in 
the most peripheral regions of the South and East CRS.
Figure 2. I) Local empirical Bayesian mortality rate (/100,000 women aged 20 years and over – year) 
standardized by age, according to the year of death. Municipality of São Paulo, 2000–2016 (three years 
and two years). A-I) for breast cancer. B-I) for cervical cancer. II) Spatial agglomerates of the Bivariate 
Local Moran Index - mortality rate standardized by age, in relation to the socioeconomic domain of the 
São Paulo Social Vulnerability Index (DS-IPVS) - according to Areas of Coverage of Basic Health Units. 
Municipality of São Paulo, 2000–2016. A-II) for breast cancer. B-II) for cervical cancer.
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For the CC, in the West, Downtown and part of the Southeast CRS, areas of “low-high” 
pattern predominated (low mortality rates and high DS-IPVS values in the neighbors). In the 
North (upper), East and South CRS, there was a predominance of “high-low” agglomerates 
(high mortality rates and low DS-IPVS values in the neighbors), mixed with “low-low” 
agglomerates (low mortality rates and low DS-IPVS values in the neighbors).
Figures 3A and 3B show the temporal evolution of the mortality rates standardized for 
both cancers, in the MSP as a whole and according to the CA, respectively. There is a trend 
of increase in mortality from BC until the period 2006-2008, followed by a slight decrease 
(Figure 3A). As for mortality from CC, there was a noticeable decrease between the beginning 
and the end of the period, with slight stabilization in 2009–2011.
In Figure 3B, it is possible to identify that, for mortality from BC, there was a trend, over 
time, of reduced variability of the data, identified by a decrease in the amplitude of outlier 
values. For mortality from CC, variation was higher in the first period (2000-2002) than in 
the others, with a gradual, but discrete reduction of the median value over time. In both 
cancers, the distance between the first and third quartiles narrowed over time.
Figure 3. A) Mortality rate (/100 thousand women aged 20 years and over – year) due to breast and cervical 
cancers, standardized by age, according to the year of death. Municipality of São Paulo, 2000–2016 
(three years and two years). B) Local empirical Bayesian mortality rate (/ 100,000 women aged 20 years 
and over – year) from breast and cervical cancers, standardized by age, second year of death and Areas 
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Temporal evolution of mortality rates standardized for BC and CC is also shown as in 
the form of maps according to CA (Figure 4). We observed, over time, that the pattern of 
spatial distribution of mortality due to BC was inconstant. In the Downtown and West CRS, 
Figure 4. Mortality rates (MR) (/100 thousand women aged 20 years and over – year) standardized by age, according to year of death 
and Areas of Coverage of Basic Health Units. Municipality of São Paulo, 2000–2016 (three years and two years). I-A) For breast cancer 
2000–2002. I-B) For breast cancer 2003–2005. I-C) For breast cancer, 2006-2008. I-D) For breast cancer, 2009–2011. I-E) For breast cancer, 
2012–2014.I-F) For breast cancer, 2015–2016. II-A) For cervical cancer, 2000–2002. II-B) For cervical cancer, 2003–2005. II-C) For cervical 
cancer, 2006–2008. II-D) For cervical cancer, 2009–2011. II-E) For cervical cancer, 2012–2014. II-F) For cervical cancer, 2015–2016.
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an apparent reduction in mortality was observed over the years. In addition, the number of 
areas with rates above 32 deaths per 100 thousand women-year, last category, represented 
in the darkest color on the maps, decreased over time. This pattern is coherent with the 
curve of the entire MSP, shown in Figure 3A; however, it is worth noting that the last period 
only comprises two years.
In general, over time, the pattern of spatial distribution of mortality from CC remained 
with the highest mortality rates located in peripheral regions. However, but also coherent 
with Figure 3A, there is a tendency of reduced mortality rate from this cancer, in terms of 
geographical and value dispersion, over the years of the study. The large number of areas 
with value 0 in the last period (2015–2016) stands out, with 19 CA without record of deaths 
from CC.
The Table shows the overall values, for both cancers, of mortality rates standardized by 
age; rates stratified by age groups, with a ratio of comparison between them; and mortality 
associated to socioeconomic conditions (DS-IPVS). It is noteworthy that mortality values for 
BC were always higher, with an increase in this difference as the age stratum increases. In 
addition, the global Moran index reaffirms the results of the direct association of DS-IPVS 
with mortality from BC, and inverse with that from CC.
In the year-by-year analysis, we found that the younger age group showed a trend of 
stability in mortality from BC, but of increased mortality from CC, especially after the 
period 2006-2008. On the other hand, the age group from 40 to 69 years showed a tendency 
of stability for mortality from BC and of decline for mortality from CC. In the age group 
of 70 years of over, mortality from BC denoted a slight downward trend, with peaks in the 
periods 2006–2008 and 2015–2016, while mortality from CC showed a sharp downward 
trend, peaking in the period 2009–2011.
DISCUSSION
This study allowed to evidence the spatial pattern of mortality from breast and cervical 
cancer over time, associated with socioeconomic conditions of the MSP. With this, 
we identified that BC, throughout the period, denotes a pattern, with higher rates located 
in the central regions with better socioeconomic conditions, but with a decrease at the 
end of the period and apparent change of pattern, and increased mortality in peripheral 
regions. On the other hand, the highest rates of mortality from CC continued in peripheral 
regions with worse socioeconomic conditions, despite decreasing over the study period.
Table. Distribution of overall mortality rates, ratio between rates and bivariate global Moran index, 
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Therefore, an important finding of this study is that, for BC, in the entire period, there 
was a direct relation between areas with higher mortality rates and areas with better 
socioeconomic conditions. For CC, the behavior was the opposite. These relations were 
expressed not only descriptively, but also with the significant values of the global and local 
Moran indexes.
This result agrees with the descriptive study performed by Neves and Naffah6, which 
evidenced an apparent association between areas with high mortality from BC and areas 
with better socioeconomic conditions, and the inverse pattern for CC, in the MSP, from 
2010–2012. Another ecological study, conducted by Rocha-Brischiliari et al.13, found, in the 
state of Paraná, in 2009–2012, a positive and significant relation between mortality from 
BC and greater access to health services; and a negative one in relation to the illiteracy rate. 
Similarly, in the state of São Paulo, between 2006–2012, Diniz et al.14 found a positive and 
significant association between areas with high mortality from BC and areas with high 
mammography rates, higher nulliparity and greater private medical care.
The causes of increased mortality for women with better socioeconomic situation may be 
linked to the higher exposure to carcinogens, and lower occurrence of protective factors in 
this group14. As they have more access to health services, they are more exposed to factors 
associated with breast cancer, such as hormonal contraception, hormone replacement 
therapy in menopause and a higher concentration of mammograms (increased ionizing 
radiation) and breast biopsies. Because they are more subject to overdiagnosis, they may 
suffer more from the cardiotoxic effects of chemotherapy and hormone therapy, as well as 
the carcinogenic effects of radiotherapy15.
Studies allow to estimate that, when adding damages potentially associated with cancer 
treatments, despite the decreased mortality due to the specific cause (breast cancer), 
there may be an increase in mortality due to the set of causes, mainly due to increased 
cardiovascular mortality and from other cancers16. In addition, the reproductive 
characteristics of these women are less protective: they have fewer children (therefore, 
with lower chances of breastfeeding) and have them later in life17. In the same line, 
a meta-analysis and systematic review study conducted in Europe pointed to a higher and 
significant mortality from BC in women with higher socioeconomic level. As explanation, 
they listed reproductive factors, mammographic screening, hormone replacement therapy 
and lifestyle-related factors18.
Our study also showed that, for BC, there was a downward trend in the rates of the 
municipality at the end of the analyzed period. In addition, over time, there was a 
narrowing of data variability per unit of analysis. Also, we observed an apparent change 
in the spatial distribution of mortality, with increased rates in peripheral regions and 
reduction in central regions of the MSP. Thus, analyzing all these results together, we 
expect that, currently, the spatial pattern of mortality from BC tends to a uniform 
distribution in the municipality.
Similarly, mortality from BC has been declining in developed countries19-21, which is 
associated with less aggressive, more effective and safe treatments and a reduced use of 
estrogen replacement therapy in these populations9,22,23. It has also been declining in Brazil 
and in the Southeast region of the country, despite increasing trends in the North and 
Northeast regions24,25. Barbosa et al.24 indicated, in their study on mortality projections for 
this cancer until 2030, that the highest rates will be recorded in the less developed regions 
of Brazil. Late diagnosis is placed, by that and another study24,26, as a possible explanation 
for the increased mortality expected in poorer regions. However, there may also be an 
association between greater coverage of mammographic screening and increased mortality 
from BC (due to aspects such as overdiagnosis and over-treatment14,16,22,23).
The ecological study of Harding et al.22 in the United States, comparing the regions and the 
screening rates among more than 16 million women, found that, the higher the screening 
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rate by mammography, the higher the incidence of breast cancer, without implying a 
reduction in mortality from this cancer. That study also found a non-significant association 
between screening and increased mortality specifically from breast cancer. In the study 
by Rocha-Brischiliari et al.13, not only was there an association between the greater use of 
diagnostic services and higher mortality, but they also noted an increased mortality when 
there is greater proximity to specialized services in the patients’ housing region. Those 
findings go in the same direction as in our study and may help explain why increased 
screening coverage is associated with an increased mortality in poorer areas.
For mortality from CC, there is also a decrease of values over time for the entire MSP, and 
apparent reduction in dispersion in the units of analysis, but without changes in the spatial 
pattern. That is, the highest rates continue to be in the more peripheral regions throughout 
the study period. This is an equally important result; the decrease is probably explained 
by the increased screening coverage in the municipality, which provides detection and 
treatment of precursor lesions, although it is still unequal, with less access in peripheral 
regions27,18. This decrease agrees with the temporal trend profile of mortality from this 
cancer in Brazil and its regions, except for the North region25,29. In relation to the analyses 
stratified by age group, the youngest group (20–39 years) was the only with an increase 
trend, a phenomenon that has also been observed in European countries30.
It is also worth considering that the value shown regarding the overall mortality rate for 
BC in the municipality was more than twice the world average in 2018. As for CC, the value 
found was slightly lower than the world average. It is noteworthy that these world rates are 
standardized according to the same standard population, but without the filter for women 
aged 20 years or over1.
Some limitations of this study are related to the use of secondary data, subject to different 
degrees of information quality; and to the estimates made to calculate the population 
of non-census years, since the precision of these estimates decreases as they distance 
themselves from census years. The following are also limitations: (i) non-consideration of 
census sectors with less than 50 permanent private households to calculate the IPVS of 
the CA, and (ii) extrapolation of information from the census sector level to these units of 
analysis, since the census delimitations do not correspond to those of the CA. This problem 
was solved with spatial analysis tools. In addition, there is the issue of random fluctuation, 
which occurs due to the existence of areas with small populations, minimized by the use 
of local empirical Bayesian methodology and grouping into periods.
As strengths, we highlight that the estimates relied on geoprocessing tools, and that a wide 
study period was used. In addition, the quality of mortality records in the MSP resulted in a 
high success rate of geocoding (98.9%), indicating, among other factors, a good completion 
of death certificates.
Knowledge on spatial and temporal patterns allows a better targeting of resources to prevent 
and promote health in the territories. It also raises questions that may be more explored by 
other studies aimed at better clarifying the reasons for the different behaviors.
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